FDA 483 - Rosa M. Suarez, M.D. - March 10, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Rosa M. Suarez, Clinical Investigator, received a Form 483 following an FDA inspection in Miami, FL, citing significant deviations in clinical trial conduct. Observations included failures to adhere to investigational plans, such as enrolling subjects who did not meet criteria, incorrect product randomization and administration, and inadequate case histories. Additionally, informed consent procedures were not properly followed, with some protocol-specific procedures performed before subjects signed consent forms.
ID · fb573f0b-dc87-4cef-8e6d-ce0a30688486